| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 03/29/2001 | CA2805979A1 Inhibition of secretiion from non-neuronal cells |
| 03/29/2001 | CA2385424A1 Method for the selective protection of proliferating normal cells and the selective eradication of tumor cells having an inactive p53 pathway |
| 03/29/2001 | CA2385377A1 Method to identify compounds useful in the therapy of bone disorders |
| 03/29/2001 | CA2385257A1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 03/29/2001 | CA2384806A1 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383433A1 Oral recombinant lactobacilli vaccines |
| 03/29/2001 | CA2383253A1 Conditional immortalisation of cells |
| 03/29/2001 | CA2383093A1 Cell-based gene therapy for the pulmonary system |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086207A1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 03/28/2001 | EP1085923A1 Accelerated gas removal from divers' tissues utilizing gas metabolizing bacteria |
| 03/28/2001 | EP1085904A1 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals |
| 03/28/2001 | EP1085816A1 Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 03/28/2001 | EP0831897B1 In ovo vaccination against coccidiosis |
| 03/28/2001 | EP0759087B1 Compositions and methods for targeting gene delivery vehicles |
| 03/28/2001 | CN1289252A Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway |
| 03/28/2001 | CN1289251A synergistic mixtures of natural products |
| 03/28/2001 | CN1288753A Dermatosis treating ointment |
| 03/28/2001 | CN1288749A Medicated sanitary article for treating gynopathy and its preparation |
| 03/28/2001 | CN1288745A Preparation of externally applied Chinese medicine |
| 03/28/2001 | CN1288741A Scald treating ointment resulting in no scar |
| 03/28/2001 | CN1288736A Medicine for protrusion of lumber vertebral disc and its preparation |
| 03/28/2001 | CN1288733A Compound preparation containing medicinal active bacteria and its preparation |
| 03/28/2001 | CN1288732A Soft concentrated fish oil capsule and its supercritical CO2 extraction and rectification process |
| 03/28/2001 | CN1288731A Slow-releasing concentrated fish oil tablet and its preparation |
| 03/28/2001 | CN1063666C Oil-state fine medicinal powder preparation for treating carbuncle, sore and preparation method thereof |
| 03/28/2001 | CN1063664C Chinese medicine for treating gastrosis |
| 03/28/2001 | CN1063663C Medicine for treating colonitis and preparation method |
| 03/28/2001 | CN1063661C Traditional chinese medicine for treating gastric disease and preparation process thereof |
| 03/28/2001 | CN1063660C Chinese medicine preparation for curing residual jaundice of viral hepatitis |
| 03/28/2001 | CN1063659C Chinese plaster for curing liver diseases and its preparation method |
| 03/28/2001 | CN1063657C Medicinal liquor for treating hoary hair, flavism and alopecia areata and preparation method |
| 03/28/2001 | CN1063655C Pure traditional Chinese medicine concentrated capsule for treating hepatitis B |
| 03/28/2001 | CN1063651C Decoction for treating cancer |
| 03/28/2001 | CN1063650C Chinese medicinal pill for treating rheumatism and rheumatoid disease and preparation method |
| 03/28/2001 | CN1063648C Chinese medicinal preparation for treating cancer |
| 03/28/2001 | CN1063639C Powder medicine for setting broken bone and traditional Chinese dray plastic material containing it |
| 03/28/2001 | CN1063638C Scorpion-venom injecta and preparation method thereof |
| 03/28/2001 | CN1063637C Preparation of ethanol extracted earthworm tissue liquid |
| 03/28/2001 | CN1063636C Production process for protease hydrolyzed pearl solution |
| 03/28/2001 | CN1063635C Medicine for treating epilepsy |
| 03/28/2001 | CN1063634C Medicine for treating cirrhosis and preparation method |
| 03/28/2001 | CN1063633C Chinese medicine for treating ophthalmopathy |
| 03/28/2001 | CN1063631C 乳酸软膏 Lactic acid ointment |
| 03/27/2001 | US6207803 Amino acid sequence of polypeptide; anticarcinogenic agents; antitumor agents; treatment of automimmune disorders, blood disorders; alzheimer's/parkinson's disease, septic shock, osteoporosis, polycystic kidney disease; viricides; diagnosis |
| 03/27/2001 | US6207638 For enhancing and extending post meal satiety by stimulating cholecystokinin levels in a calorically efficient manner for reducing weight, comprising protein consisting of casein, whey and soy, glycomacropeptide, long chain fatty acids, fibers |
| 03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
| 03/27/2001 | US6207451 Includes substrate, separate anchors joined to substrate, and myogenic precursor cells; anchors allow cells to attach to form three dimensional construct; drug screening; toxicity testing; gene therapy; screening of congenital disorders |
| 03/27/2001 | US6207411 Bacteriocins |
| 03/27/2001 | US6207200 Administering an antiviral protein to patient infected with human immunodefficiency virus type i |
| 03/27/2001 | US6207147 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 03/27/2001 | US6207063 Blood processing systems and methods using apparent hematocrit as a process control parameter |
| 03/27/2001 | US6206931 Purified, biocompatible, collagen-based matrix structure from submucosa tissue source with an endotoxin level of 12 or less units per gram |
| 03/27/2001 | US6206914 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019966A2 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | WO2001019965A1 Methods and compositions for preserving chondrocytes and uses |
| 03/22/2001 | WO2001019964A1 Chondrocyte compositions, preparation and use thereof |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019824A2 New active marine alkaloids |
| 03/22/2001 | WO2001019430A1 Method and cycler for peritoneal dialysis |
| 03/22/2001 | WO2001019413A1 Method and apparatus for producing a sterile fluid |
| 03/22/2001 | WO2001019387A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | WO2001019380A2 Oncolytic virus |
| 03/22/2001 | WO2001019379A2 Methods for treating muscular dystrophy with bone marrow cells |
| 03/22/2001 | WO2001019378A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 03/22/2001 | WO2001019374A2 Glucosamine and egg reducing inflammation |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001019158A2 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 03/22/2001 | WO2001007098A3 A device and method for performing a biological modification of a fluid |
| 03/22/2001 | WO2000074629A3 Composition for implementing a cytotoxic, in particular an antitumoral or antiviral, treatment in a mammal |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000069862A3 Hemisynthetic method and intermediates thereof |
| 03/22/2001 | WO2000067696A3 Lactic acid bacteria with anxiolytic properties and uses thereof |
| 03/22/2001 | WO2000063242A8 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/22/2001 | WO2000056861A8 Methods of microencapsulating pancreatic islet cells |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000029443A9 Contraceptive antibody vaccines |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384768A1 Methods and compositions for preserving chondrocytes and uses |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384656A1 New active marine alkaloids |
| 03/22/2001 | CA2384246A1 Glucosamine and egg reducing inflammation |
| 03/22/2001 | CA2384081A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | CA2383923A1 Method and apparatus for producing a sterile fluid |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/21/2001 | EP1085085A1 Process for reducing specific immune reactions |